Page 110 - Read Online

Link et al. Roles of p53 in extrinsic factor-induced liver carcinogenesis

to vinyl chloride. J Natl Cancer Inst 1995;87:1400-7. 73.
45. Barbin A, Froment O, Boivin S, Marion MJ, Belpoggi F, Maltoni C, 64. Asare GA, Paterson AC, Kew MC, Khan S, Mossanda KS. Iron-free
Montesano R. p53 gene mutation pattern in rat liver tumors induced neoplastic nodules and hepatocellular carcinoma without cirrhosis
by vinyl chloride. Cancer Res 1997;57:1695-8. in Wistar rats fed a diet high in iron. J Pathol 2006;208:82-90.
46. Smith SJ, Li Y, Whitley R, Marion MJ, Partilo S, Carney WP, 65. Kang JO, Jones C, Brothwell B. Toxicity associated with iron
Brandt-Rauf PW. Molecular epidemiology of p53 protein mutations overload found in hemochromatosis: possible mechanism in a rat
in workers exposed to vinyl chloride. Am J Epidemiol 1998;147:302- model. Clin Lab Sci 1998;11:350-4.
8. 66. Jungst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers
47. Calzadilla Bertot L, Adams LA. The natural course of non- J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH.
alcoholic fatty liver disease. Int J Mol Sci 2016;17:774. Oxidative damage is increased in human liver tissue adjacent to
48. Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an hepatocellular carcinoma. Hepatology 2004;39:1663-72.
update. World J Gastroenterol 2014;20:9050-4. 67. Asare GA, Mossanda KS, Kew MC, Paterson AC, Kahler-Venter
49. Baffy G. Hepatocellular carcinoma in non-alcoholic fatty liver CP, Siziba K. Hepatocellular carcinoma caused by iron overload:
disease: epidemiology, pathogenesis, and prevention. J Clin Transl a possible mechanism of direct hepatocarcinogenicity. Toxicology
Hepatol 2013;1:131-7. 2006;219:41-52.
50. Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, 68. Shen J, Sheng X, Chang Z, Wu Q, Wang S, Xuan Z, Li D, Wu Y,
Schlaak JF, Gerken G, Syn WK, Canbay A. Non-alcoholic fatty Shang Y, Kong X, Yu L, Li L, Ruan K, Hu H, Huang Y, Hui L, Xie
liver disease progresses to hepatocellular carcinoma in the absence D, Wang F, Hu R. Iron metabolism regulates p53 signaling through
of apparent cirrhosis. Int J Cancer 2011;128:2436-43. direct heme-p53 interaction and modulation of p53 localization,
51. Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular stability, and function. Cell Rep 2014;7:180-93.
carcinoma and consequences for treatment. Oncologist 2010;15 69. Bloomer SA, Brown KE. Tumour promotion versus tumour
Suppl 4:14-22. suppression in chronic hepatic iron overload. Cell Biochem Funct
52. Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver 2015;33:241-8.
cancer. Nat Rev Gastroenterol Hepatol 2013;10:656-65. 70. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Post-transcriptional
53. Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, modulation of iron homeostasis during p53-dependent growth
Shimamura K, Nishiyama K, Mataki N, Irie R, Minamino T, Okada arrest. J Biol Chem 2008;283:33911-8.
Y, Kurihara C, Ebinuma H, Saito H, Shimizu I, Yoshida Y, Hokari 71. Funauchi Y, Tanikawa C, Yi Lo PH, Mori J, Daigo Y, Takano A,
R, Sugiyama K, Hatsuse K, Yamamoto J, Kanai T, Miura S, Hibi Miyagi Y, Okawa A, Nakamura Y, Matsuda K. Regulation of iron
T. p53/p66Shc-mediated signaling contributes to the progression homeostasis by the p53-ISCU pathway. Sci Rep 2015;5:16497.
of non-alcoholic steatohepatitis in humans and mice. J Hepatol 72. Vaut ie r G, Bom ford A B, Por t ma n n BC, Met iv ie r E ,
2012;57:837-43. Williams R, Ryder SD. p53 mutations in british patients with
54. Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, hepatocellular carcinoma: clustering in genetic hemochromatosis.
Cortez-Pinto H, Rodrigues CM. miR-34a/SIRT1/p53 is suppressed Gastroenterology 1999;117:154-60.
by ursodeoxycholic acid in the rat liver and activated by disease 73. Marrogi AJ, Khan MA, van Gijssel HE, Welsh JA, Rahim H,
severity in human non-alcoholic fatty liver disease. J Hepatol Demetris AJ, Kowdley KV, Hussain SP, Nair J, Bartsch H, Okby
2013;58:119-25. N, Poirier MC, Ishak KG, Harris CC. Oxidative stress and p53
55. Tian XF, Ji FJ, Zang HL, Cao H. Activation of the miR-34a/SIRT1/ mutations in the carcinogenesis of iron overload-associated
p53 signaling pathway contributes to the progress of liver fibrosis hepatocellular carcinoma. J Natl Cancer Inst 2001;93:1652-5.
via inducing apoptosis in hepatocytes but not in HSCs. PLoS One 74. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology
2016;11:e0158657. of hepatitis B virus infection: new estimates of age-specific HBsAg
56. Ferreira DM, Afonso MB, Rodrigues PM, Simao AL, Pereira DM, seroprevalence and endemicity. Vaccine 2012;30:2212-9.
Borralho PM, Rodrigues CM, Castro RE. c-Jun N-terminal kinase 75. Chan SL, Wong VW, Qin S, Chan HL. Infection and cancer: the
1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway case of hepatitis B. J Clin Oncol 2016;34:83-90.
contributes to apoptosis induced by deoxycholic acid in rat liver. 76. Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular
Mol Cell Biol 2014;34:1100-20. mechanism of hepatitis B virus-induced hepatocarcinogenesis.
57. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the World J Gastroenterol 2014;20:11630-40.
feedback loop. Cell Cycle 2009;8:712-5. 77. El-Serag HB, Rudolph KL. Hepatocellular carcinoma:
58. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore epidemiology and molecular carcinogenesis. Gastroenterology
M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein 2007;132:2557-76.
CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Transactivation of 78. Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis
miR-34a by p53 broadly influences gene expression and promotes B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol
apoptosis. Mol Cell 2007;26:745-52. 2011;26:144-52.
59. Chifman J, Laubenbacher R, Torti SV. A systems biology approach 79. Datta S, Chatterjee S, Veer V, Chakravarty R. Molecular biology of
to iron metabolism. Adv Exp Med Biol 2014;844:201-25. the hepatitis B virus for clinicians. J Clin Exp Hepatol 2012;2:353-
60. Siddique A, Kowdley KV. Review article: the iron overload 65.
syndromes. Aliment Pharmacol Ther 2012;35:876-93. 80. Seeger C, Mason WS. Molecular biology of hepatitis B virus
61. Heeney MM. Iron clad: iron homeostasis and the diagnosis of infection. Virology 2015;479-480:672-86.
hereditary iron overload. Hematology Am Soc Hematol Educ 81. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of
Program 2014;2014:202-9. hepatitis B virus induces liver cancer in transgenic mice. Nature
62. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev 1991;351:317-20.
Cancer 2013;13:342-55. 82. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson
63. Kew MC. Hepatocellular carcinoma in African Blacks: recent MA, Jay G. Functional inactivation but not structural mutation of
progress in etiology and pathogenesis. World J Hepatol 2010;2:65- p53 causes liver cancer. Nat Genet 1995;9:41-7.
102 Hepatoma Research ¦ Volume 3 ¦ June 6, 2017